Relation of Some Immunological Markers (IL 4, 12 and 23) with Toxoplasmosis in Aborted Women
Keywords:
Toxoplasma gondii, Abortion, IL-4, IL12, IL 23.Abstract
Toxoplasma gondii is a major cause of abortion in pregnant women. Toxoplasmosis infection in the mother during pregnancy is frequently associated with transplacental transmission of the parasite to the fetus. The purpose of this study Aims of this study determine and compared the different concentrations level of interleukin (IL) 4, 12 &23 in patients with toxoplasmosis and control groups. From September 2020 to May 2021, a case-control study was carried out in Thi-Qar province to estimate the role of Toxoplasmosis in the occurrence of abortion among pregnant women. The current study included 120 aborted women as well as 20 healthy women as controls (Non pregnant and have no clinical history of abortion). All of these cases involved only females of reproductive age (16-44 years). Toxo-IgM and Toxo-IgG antibodies were tested first with a latex agglutination test (LAT) to detect positive samples, followed by an Enzyme Linked Immunesorbent Assay (ELISA) to detect IgG and IgM antibodies in both groups. CUSABIO method for measuring human interferon (IFN-) and 2-human cluster of differentiation 4 (CD4) (USA). IL-12 value in a patient with IgM was (48.59) which is significantly higher than the control patient value (38.69). Also, IL12 value of patients with Toxo IgG (57.48) was significantly higher than the control patient. IL-23 values of a patient with Toxo- IgG, and Toxo- IgM were (77.92&57.92) respectively which is significantly higher than the control patient value (38.38). IL-4 value in a patient with Toxo- IgG was (35.83) and Toxo- IgM was (42.67) which is significantly higher than the control patient value (25.90).
Downloads
References
Aghwan, S. S .; Al-Taee, A. F .; & Suliman, E. G. (2010).
Detection of Toxoplasma gondii infection in domestic
rabbits by using multiple techniques. Iraqi Journal of
Veterinary Sciences, 24(2): 65–69.
Alvarez, C. (2021). Immunity-related GTPases (IRGs) in the
house mouse and the parasite Toxoplasma gondii in
South America.
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B.,
Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T.,
Zurawski, S., Wiekowski, M., Lira, S. A., Gorman, D.,
Kastelein, R. A., & Sedgwick, J. D. (2003). Interleukin-23
rather than interleukin-12 is the critical cytokine for
autoimmune inflammation of the brain. Nature,
(6924), 744–748.
https://doi.org/10.1038/nature01355
Dubey, J. P. (2020). The history and life cycle of
Toxoplasma gondii. In Toxoplasma gondii (Issue 1909,
pp. 1–19). Elsevier. https://doi.org/10.1016/B978-0-12-
-2.00001-3
El-Shazly, A. M., Azab, M. S., El-Beshbishi, S. N., El-Nahas,
H. A., AA, A. M., Mel-S, M., & Morsy, T. A. (2005). Some
molecular aspects in schistosomiasis mansoni and
toxoplasmosis. Journal of the Egyptian Society of
Parasitology, 35(3), 795–808.
Ham, D. W., Kim, S. G., Seo, S. H., Shin, J. H., Lee, S. H., &
Shin, E. H. (2020). Chronic Toxoplasma gondii Infection
Alleviates Experimental Autoimmune Encephalomyelitis
by the Immune Regulation Inducing Reduction in IL-
A/Th17 Via Upregulation of SOCS3.
Neurotherapeutics. https://doi.org/10.1007/s13311-020-
-9
Hussain, M. A., Stitt, V., Szabo, E. A., & Nelan, B. (2017).
Toxoplasma gondii in the food supply. Pathogens, 6(2).
https://doi.org/10.3390/pathogens6020021
Ismail, H. A. H. A., Kang, B.-H., Kim, J.-S., Lee, J.-H., Choi, I.-
W., Cha, G.-H., Yuk, J.-M., & Lee, Y.-H. (2017). IL-12 and
IL-23 Production in Toxoplasma gondii- or LPS-Treated
Jurkat T Cells via PI3K and MAPK Signaling Pathways.
The Korean Journal of Parasitology, 55(6), 613–622.
https://doi.org/10.3347/kjp.2017.55.6.613
Jeffers, V., Tampaki, Z., Kim, K., & Sullivan, W. J. (2018). A
latent ability to persist: differentiation in Toxoplasma
gondii. Cellular and Molecular Life Sciences, 75(13),
–2373.
Khan, I. A., Matsuura, T., & Kasper, L. H. (1994). Interleukin-
enhances murine survival against acute
toxoplasmosis. Infection and Immunity, 62(5), 1639–
https://doi.org/10.1128/iai.62.5.1639-1642.1994
Lieberman, L. A., Cardillo, F., Owyang, A. M., Rennick, D. M.,
Cua, D. J., Kastelein, R. A., & Hunter, C. A. (2004). IL-23
Provides a Limited Mechanism of Resistance to Acute
Toxoplasmosis in the Absence of IL-12. The Journal of
Immunology, 173(3), 1887–1893.
https://doi.org/10.4049/jimmunol.173.3.1887
Mammari, N., Halabi, M. A., Yaacoub, S., Chlala, H., Dardé,
M. L., & Courtioux, B. (2019). Toxoplasma gondii
Modulates the Host Cell Responses: An Overview of
Apoptosis Pathways. BioMed Research International,
https://doi.org/10.1155/2019/6152489
Mencacci, A., Cenci, E., Del Sero, G., d’Ostiani, C. F., Mosci,
P., Trinchieri, G., Adorini, L., & Romani, L. (1998). IL-10 is
required for development of protective Th1 responses in
IL-12-deficient mice upon Candida albicans infection.
The Journal of Immunology, 161(11), 6228–6237.
Mercer, H. L., Snyder, L. M., Doherty, C. M., Fox, B. A., Bzik,
D. J., & Denkers, E. Y. (2020). Toxoplasma gondii dense
granule protein GRA24 drives MyD88-independent p38
MAPK activation, IL-12 production and induction of
protective immunity. PLoS Pathogens, 16(5), 1–24.
https://doi.org/10.1371/journal.ppat.1008572
Nickdel, M. B., Lyons, R. E., Roberts, F., Brombacher, F.,
Hunter, C. A., Alexander, J., & Roberts, C. W. (2004).
Intestinal pathology during acute toxoplasmosis is IL-4
dependent and unrelated to parasite burden. Parasite
Immunology, 26(2), 75–82. https://doi.org/10.1111/j.0141-
2004.00686.x
Nyonda, M. (2021). Toxoplasma gondii sphingolipids and an
effector protein at the nexus of parasite development.
University of Geneva.
Pedras‐Vasconcelos, J. A., Brunet, L. R., & Pearce, E. J.
(2001). Profound effect of the absence of IL‐4 on T cell
responses during infection with Schistosoma mansoni.
Journal of Leukocyte Biology, 70(5), 737–744.
Quan, J.-H., Zhou, W., Cha, G.-H., Choi, I.-W., Shin, D.-W., &
Lee, Y.-H. (2013). Kinetics of IL-23 and IL-12 secretion in
response to Toxoplasma gondii antigens from THP-1
monocytic cells. The Korean Journal of Parasitology,
(1), 85.
Roberts, C. W., Ferguson, D. J. P., Jebbari, H., Satoskar, A.,
Bluethmann, H., & Alexander, J. (1996). Different roles
for interleukin-4 during the course of Toxoplasma gondii
infection. Infection and Immunity, 64(3), 897–904.
https://doi.org/10.1128/iai.64.3.897-904.1996
Scanga, C. A., Aliberti, J., Jankovic, D., Tilloy, F., Bennouna,
S., Denkers, E. Y., Medzhitov, R., & Sher, A. (2002).
Cutting edge: MyD88 is required for resistance to
Toxoplasma gondii infection and regulates parasiteinduced IL-12 production by dendritic cells. The Journal
of Immunology, 168(12), 5997–6001.
Schade, B., & Fischer, H. G. (2001). Toxoplasma gondii
induction of interleukin-12 is associated with acute
virulence in mice and depends on the host genotype.
Veterinary Parasitology, 100(1–2), 63–74.
https://doi.org/10.1016/S0304-4017(01)00484-8
Sibley, L. D. (2017). Genetic analysis of pathogenesis in
Toxoplasma gondii. The FASEB Journal, 31, 270–271.
Sparvoli, D., & Lebrun, M. (2021). Unraveling the Elusive
Rhoptry Exocytic Mechanism of Apicomplexa. Trends in
Parasitology.
TAli, A., SMahdi, D., & Awad, A. (2019). SEROPREVALENCE
OF TOXOPLASMA GONDII ANTIBODIES IN ABORTED
WOMEN USING ENZYME LINKED IMMUNESORBENT
ASSAY(ELISA) IN THI-QAR PROVINCE, IRAQ.
International Journal of Advanced Research, 7(1), 629–
https://doi.org/10.21474/IJAR01/8371
Villard, O., Candolfi, E., Despringre, J. L., Derouin, F.,
Marcellin, L., Viville, S., & Kien, T. (1995). Protective
effect of low doses of an anti‐IL‐4 monoclonal antibody
in a murine model of acute toxoplasmosis. Parasite
Immunology, 17(5), 233–236.
Yamamoto, M., Okuyama, M., Ma, J. S., Kimura, T., Kamiyama, N., Saiga, H., Ohshima, J., Sasai, M., Kayama, H., & Okamoto, T. (2012). A cluster of interferon-γ-inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii. Immunity, 37(2), 302–313.
Zhang, Y., Lai, B. S., Juhas, M., & Zhang, Y. (2019). Toxoplasma gondii secretory proteins and their role in invasion and pathogenesis. Microbiological Research, 227, 126293.
Downloads
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
